Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Antidepressant Drugs: Overview

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...

Depression: Overview

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Depressive Disorders: Etiology

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...

Decision Making

Decision Making

Decision-making is a fundamental cognitive process that involves evaluating alternatives and selecting among them. This process can range from simple choices, such as deciding what to wear, to complex decisions, like choosing a major in college or a career path. The complexity of the decision often dictates the approach we use, which can be broadly categorized into two types: automatic and controlled decision-making.
Automatic decision-making is fast, intuitive, and relies on gut feelings...

Depressive Disorders: MDD and Dysthymia

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

New Caregiver Diagnoses of Severe Depression and Child Asthma Controller Medication Adherence.

International journal of environmental research and public health·2023

Same author

Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic.

JAMA network open·2021

Same author

Trends in Drug Overdose Mortality in Ohio During the First 7 Months of the COVID-19 Pandemic.

JAMA network open·2021

Same author

E-cigarette minimum legal sale age laws and traditional cigarette use among rural pregnant teenagers.

Journal of health economics·2019

Same author

INEQUALITY IN MORTALITY OVER THE LIFE COURSE: WHY THINGS ARE NOT AS BAD AS YOU THINK.

Contemporary economic policy·2019

Same author

Diagnosing Expertise: Human Capital, Decision Making, and Performance among Physicians.

Journal of labor economics·2017

Search research articles

Related Experiment Video

Updated: Dec 7, 2025

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

UNDERSTANDING DOCTOR DECISION MAKING: THE CASE OF DEPRESSION TREATMENT.

Janet M Currie¹, W Bentley Macleod²

¹Woodrow Wilson School, Princeton University and NBER.

Econometrica : Journal of the Econometric Society

|September 28, 2020

Summary

This summary is machine-generated.

Skilled doctors improve depression treatment outcomes by diversifying drug choices, but only when adhering to professional guidelines. Behavioral models show diagnostic skill enhances this drug selection process.

Keywords:

Decision theory bounded rationality expert decision making human capital learning

More Related Videos

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Published on: November 21, 2025

Related Experiment Videos

Last Updated: Dec 7, 2025

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Published on: November 21, 2025

Area of Science:

Behavioral economics
Health economics
Medical decision-making

Background:

Depression treatment involves complex decisions balancing known effective treatments with exploring new options.
Physician decision-making in treatment selection can impact patient outcomes.

Purpose of the Study:

To investigate the relationship between physician decision-making strategies and patient outcomes in depression treatment.
To develop a behavioral model explaining how diagnostic skill influences treatment choices and outcomes.

Main Methods:

Analysis of large-scale patient claims data to observe physician prescribing patterns.
Development of a behavioral model incorporating diagnostic skill and exploration-exploitation trade-offs.
Simulations to test model predictions regarding drug choice diversity and performance.

Main Results:

Broader drug portfolios correlate with better patient outcomes among skilled physicians, except when guidelines are violated.
Physician diagnostic skill influences the balance between treatment exploitation and experimentation.
Higher diagnostic skill leads to greater drug choice diversity and improved patient-drug matching.

Conclusions:

Physician diagnostic skill is crucial for optimizing depression treatment through diverse and appropriate drug selection.
Adherence to professional guidelines is essential for realizing the benefits of treatment exploration.
While increasing choices can be beneficial, model simulations suggest potential performance decline with excessive options.